Atlas Biotech is building functional genomics tools to de-risk oncology drug discovery. Their core technology predicts how genetic mutations drive drug response, giving pharma partners quantitative data where the industry has relied on guesswork.
Through the Radian Grant, we partnered with Atlas to translate rigorous science into a clear public narrative and investor-ready digital presence.
Overview
Atlas Biotech is building functional genomics tools to de-risk oncology drug discovery. Their core technology predicts how genetic mutations drive drug response, giving pharma partners quantitative data where the industry has relied on guesswork.
Through the Radian Grant, we partnered with Atlas to translate rigorous science into a clear public narrative and investor-ready digital presence.
The Starting Point
95% of oncology drugs fail in clinical trials
Billions lost. Patients on treatments that won’t work. The gap is prediction: pharma companies cannot reliably anticipate how a patient’s genetic mutations will affect drug response.
Josh Reynolds started Atlas to close that gap. Atlas’s core technology, quantitative deep mutational scanning (QDMS), maps every possible mutation in a drug target and measures how each one affects treatment efficacy.
Old logo
Old website
Finding the Narrative
The first challenge wasn’t design. It was comprehension.
Functional genomics is dense. Mutation profiling, drug sensitivity screening, predictive pharmacology. Each one requires real scientific literacy. Connecting them into a single platform requires translation.
We spent the early phase learning the science alongside Josh and his team. Not to simplify it. To find the single clearest path through it.
Building a New Brand Vision
We explored three directions: organic and vibrant, dark and geometric, warm with earth tones. Josh gravitated to the warmest, a topographic map texture tied to the Atlas name. A logomark referencing DNA spindle fibers from cell division gave the identity a biological foundation without being literal.
EARLY logo conceptS
Final logo concept
Logo on primary color field
Letterhead
Slide Deck
Making the Science Visible
The hero animation was the hardest design problem. The DNA helix needed to be striking and scientifically precise. Color shifts along the strand map to actual nucleotide mutations. Resistance data renders in real heat map conventions. Josh put it plainly: if you’re a scientist, you’ll notice how accurate it is.
Beyond the hero, we broke the platform into discrete visual steps: mutation libraries, cell-based screening, dose-response modeling, pharmacology-calibrated predictions. Josh had already built a workflow graphic himself. We refined that instinct and wove it into the site’s narrative flow.
What Changed
Atlas now has a communication system, not just a website.
The narrative framework extends into investor meetings, partner conversations, and pitch materials. Instead of re-explaining from scratch, the team points to a clear story and builds from there.
The site is the visible output. The real shift is in how confidently the team presents the company at a critical inflection point.
Let's talk